Inhalon Biopharma Expands Therapeutic Horizons with Licensing of hMPV Antibodies from the University of Georgia

Inhalon Biopharma today announced a new agreement with the University of Georgia to license a panel of Human Metapneumovirus (hMPV) antibodies.